Filing Flows › Gyre Therapeutics (GYRE) › Operating margin
Gyre Therapeutics (GYRE) operating margin by quarter
Gyre Therapeutics' operating margin was 22.7% in Q3 2025 (third quarter 2025), +14.5 pts from Q2 2025. Over the last 3 quarters it ranged from 8.1% (Q2 2025) to 22.7% (Q3 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | 22.7% | +14.5 pts | — |
| Q2 2025 | 8.1% | -2.2 pts | — |
| Q1 2025 | 10.3% | — | — |
Q3 2025 at a glance
Gyre Therapeutics, Q3 2025: revenue $30.6M (+20% year over year), operating margin 22.7%, net earnings $5.9M, operating cash flow $4.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Gyre Therapeutics' operating margin?
Gyre Therapeutics' operating margin was 22.7% in Q3 2025 (third quarter 2025), +14.5 pts from Q2 2025.
How has Gyre Therapeutics' operating margin changed?
Over the last 3 quarters it ranged from 8.1% (Q2 2025) to 22.7% (Q3 2025).